Phase 1/2 study of cirmtuzumab and ibrutinib in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL).

被引：16
|
作者：
Lee, Hun Ju
Choi, Michael Y.
Siddiqi, Tanya
Barrientos, Jacqueline Claudia
Wierda, William G.
Isufi, Iris
Tuscano, Joseph M.
Lamanna, Nicole
Subbiah, Suki
Koff, Jean Louise
Leslie, Lori Ann
Goldenberg, Alec
Chung, Gina G.
Breitmeyer, James Bradley
Hsu, Frank J.
Wang, Michael
Jamieson, Catriona
Kipps, Thomas J.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[2] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[3] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[4] Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Yale Univ, Sch Med, Hematol, New Haven, CT USA
[7] Univ Calif Davis, Davis, CA 95616 USA
[8] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA
[9] LSU Hlth Sci Ctr, New Orleans, LA USA
[10] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[11] John Theurer Canc Ctr, Lymphoma Res Div, Hackensack, NJ USA
[12] Manhattan Hem Onc Associates, New York, NY USA
[13] Christ Hosp, Lindner Ctr Res & Educ, Cincinnati, OH 45219 USA
[14] Oncternal Therapeut Inc, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.7556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7556
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Morphometric evaluation of peripheral blood lymphocytes in chronic lymphocytic leukemia (B-CLL) with trisomy 12 and leukemic phase of mantle cell lymphoma (MCL).
    Benattar, L
    Troussard, X
    Radford-Weiss, I
    Valensi, F
    Flandrin, G
    BLOOD, 1998, 92 (10) : 221B - 221B
  • [22] Ibrutinib for Bridging to Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) in Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Is Safe and Effective: First Results of a Survey By the Chronic Malignancy and the Lymphoma Working Parties of the EBMT
    Dreger, Peter
    Michallet, Mauricette
    Hoek, Jennifer
    Boumendil, Ariane
    Sobh, Mohamad
    Muller, Lutz
    Vandenberghe, Elisabeth A.
    Scortechini, Ilaria
    Andersen, Niels S.
    Finke, Jurgen
    Russo, Domenico
    Passweg, Jakob R.
    Schoemans, Helene
    Durakovic, Nadira
    Labussiere, Helene
    Berg, Tobias
    Niederwieser, Dietger
    Bethge, Wolfgang
    Mordini, Nicola
    van Gelder, Michel
    Schaap, Nicolaas P. M.
    Kroger, Nicolaus
    Montoto, Silvia
    Schetelig, Johannes
    BLOOD, 2016, 128 (22)
  • [23] Phase 1/2 Trial of Cirmtuzumab and Ibrutinib: Planned Analysis of Phase 1 CLL Cohorts
    O'Brien, Susan M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (07) : 18 - 19
  • [24] Characteristics of Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL) Patients Treated with Acalabrutinib in a Real World Setting in the United States
    Ryan, Kellie
    Burudpakdee, Chakkarin
    Zhao, Xiaohui
    Le, Hannah
    Near, Aimee
    BLOOD, 2019, 134
  • [25] Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL)
    Komarova, Natalia L.
    Burger, Jan A.
    Wodarz, Dominik
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (38) : 13906 - 13911
  • [26] Phase 1/2 trial of cirmtuzumab and ibrutinib: Planned analysis of phase 1 CLL cohorts.
    Choi, Michael Y.
    Wierda, William G.
    Lee, Hun Ju
    Tzachanis, Dimitrios
    Ianopulos, Xen
    Jezior, Deborah
    Breitmeyer, James Bradley
    Jamieson, Catriona H. M.
    Kipps, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma
    Sun, Yi
    Wang, Sa A.
    Sun, Tsieh
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2018, 94 (01) : 148 - 150
  • [28] Hodgkin lymphoma transformation of chronic lymphocytic leukemia (CLL) in a patient under ibrutinib therapy
    Kalpadakis, Christina
    Pangalis, Gerassimos
    Sachanas, Sotirios
    Zaroulis, Chrysothea
    Moschogiannis, Maria
    Yiakoumis, Xanthi
    Koulieris, Efstathios
    Tsirkinidis, Pantelis
    Rontogiannis, Dimitra
    LEUKEMIA & LYMPHOMA, 2017, 58 : 194 - 194
  • [29] IBRUTINIB EXPERIENCE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA: SINGEL CENTER EXPERIENCE
    Uysal, A.
    Soyer, N. Akad
    Patir, P.
    Duran, M.
    Koseoglu, F. D.
    Sahin, F.
    Vural, F.
    Tombuloglu, M.
    Saydam, G.
    LEUKEMIA RESEARCH, 2016, 49 : S35 - S35
  • [30] Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma
    O'Brien, Susan
    Hillmen, Peter
    Coutre, Steven
    Barr, Paul M.
    Fraser, Graeme
    Tedeschi, Alessandra
    Burger, Jan A.
    Dilhuydy, Marie-Sarah
    Hess, Georg
    Moreno, Carol
    Cramer, Paula
    Liu, Emily
    Chang, Stephen
    Vermeulen, Jessica
    Styles, Lori
    Howes, Angela
    James, Danelle F.
    Patel, Kalpesh
    Graef, Thorsten
    Valentino, Rudolph
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10): : 648 - +
12345